Cargando…
Mortality in patients with Sanfilippo syndrome
BACKGROUND: Sanfilippo syndrome (mucopolysaccharidosis type III; MPS III) is an inherited monogenic lysosomal storage disorder divided into subtypes A, B, C and D. Each subtype is characterized by deficiency of a different enzyme participating in metabolism of heparan sulphate. The resultant accumul...
Autores principales: | Lavery, Christine, Hendriksz, Chris J., Jones, Simon A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654004/ https://www.ncbi.nlm.nih.gov/pubmed/29061114 http://dx.doi.org/10.1186/s13023-017-0717-y |
Ejemplares similares
-
Sanfilippo syndrome: consensus guidelines for clinical care
por: Muschol, Nicole, et al.
Publicado: (2022) -
Natural history of Sanfilippo syndrome in Spain
por: Delgadillo, Verónica, et al.
Publicado: (2013) -
Is the eye a window to the brain in Sanfilippo syndrome?
por: Beard, Helen, et al.
Publicado: (2020) -
Sanfilippo syndrome: causes, consequences, and treatments
por: Fedele, Anthony O
Publicado: (2015) -
Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Valstar, Marlies J, et al.
Publicado: (2011)